HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma.

Abstract
Accumulative experimental evidence suggests feasibility of chemotherapeutic intervention targeting human cancer cells by pharmacological modulation of cellular oxidative stress. Current efforts aim at personalization of redox chemotherapy through identification of predictive tumour genotypes and redox biomarkers. Based on earlier research demonstrating that anti-melanoma activity of the pro-oxidant 2,6-dichlorophenolindophenol (DCPIP) is antagonized by cellular NAD(P)H:quinone oxidoreductase (NQO1) expression, this study tested DCPIP as a genotype-directed redox chemotherapeutic targeting homozygous NQO1*2 breast carcinoma, a common missense genotype [rs1800566 polymorphism; NP_000894.1:p.Pro187Ser] encoding a functionally impaired NQO1 protein. In a panel of cultured breast carcinoma cell lines and NQO1-transfectants with differential NQO1 expression levels, homozygous NQO1*2 MDA-MB231 cells were hypersensitive to DCPIP-induced caspase-independent cell death that occurred after early onset of oxidative stress with glutathione depletion and loss of genomic integrity. Array analysis revealed upregulated expression of oxidative (GSTM3, HMOX1, EGR1), heat shock (HSPA6, HSPA1A, CRYAB) and genotoxic stress response (GADD45A, CDKN1A) genes confirmed by immunoblot detection of HO-1, Hsp70, Hsp70B', p21 and phospho-p53 (Ser15). In a murine xenograft model of human homozygous NQO1*2-breast carcinoma, systemic administration of DCPIP displayed significant anti-tumour activity, suggesting feasibility of redox chemotherapeutic intervention targeting the NQO1*2 genotype.
AuthorsChristopher M Cabello, Sarah D Lamore, Warner B Bair 3rd, Angela L Davis, Sara M Azimian, Georg T Wondrak
JournalFree radical research (Free Radic Res) Vol. 45 Issue 3 Pg. 276-92 (Mar 2011) ISSN: 1029-2470 [Electronic] England
PMID21034357 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Heat-Shock Proteins
  • RNA, Small Interfering
  • 2,6-Dichloroindophenol
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human
  • Caspases
  • Glutathione
Topics
  • 2,6-Dichloroindophenol (pharmacology, therapeutic use)
  • Animals
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Caspases (metabolism)
  • Cell Death
  • Cell Line, Tumor
  • Cell Proliferation
  • DNA Damage
  • Female
  • Flow Cytometry
  • Gene Expression Regulation, Neoplastic
  • Glutathione (metabolism)
  • Heat-Shock Proteins (genetics)
  • Humans
  • Immunoblotting
  • Membrane Potential, Mitochondrial
  • Mice
  • NAD(P)H Dehydrogenase (Quinone) (genetics, metabolism)
  • Oxidative Stress
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide
  • RNA, Small Interfering

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: